1
Levodopa Benserazide Generic Formulation Versus the Originator
Condition(s):Parkinson DiseaseLast Updated:April 18, 2016Completed
Levodopa: 670 Clinical Trials, Page 1 of 67
Hide Studies Not Open or Pending
2
Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Condition(s):Angelman SyndromeLast Updated:November 21, 2016Completed
3
A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
Condition(s):Parkinson’s DiseaseLast Updated:July 1, 2015Completed
4
Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:August 4, 2011Completed
5
A Trial of Levodopa in Angelman Syndrome
Condition(s):Angelman SyndromeLast Updated:July 15, 2020Completed
6
A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics
Condition(s):Idiopathic Parkinson’s DiseaseLast Updated:March 29, 2013Completed
7
Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON
Condition(s):Parkinson DiseaseLast Updated:April 17, 2018Unknown status
8
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson’s Disease Taking Levodopa.
Condition(s):Parkinson DiseaseLast Updated:March 22, 2019Completed
9
Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
Condition(s):Age Related Macular DegenerationLast Updated:December 14, 2020Active, not recruiting
10
Levodopa Concentration Profile With Stalevo 75/125 mg
Condition(s):Parkinson’s DiseaseLast Updated:August 13, 2010Completed